Literature DB >> 29966947

Synchronous triple squamous cell carcinoma of the esophagus.

Andy Petroianu1, Kelly Renata Sabino2, Maurício Buzelin Nunes2.   

Abstract

BACKGROUND: Synchronous multiple primary malignancies of the esophagus and other organs are relatively unusual, but only five articles have published two synchronous cancers, both in the esophagus. This is the first published case of a triple esophageal carcinoma. CASE REPORT: A 43-year-old man was referred to our hospital with severe progressive dysphagia and epigastric pain for almost one year. Endoscopy and imaging exams revealed three tumors located in upper, middle and lower esophagus. The upper and middle esophageal cancers were irresectable, and the patient was treated with radio- and chemotherapy. He survived 11 months after the diagnosis and died due to severe undernutrition and bilateral pneumonia.
CONCLUSION: In presence of squamous cell carcinoma of the esophagus, propedeutics should be carefully performed in order to verify the occurrence of other synchronous tumors in the esophagus and other organs, mainly head and neck and bronchial regions.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Synchronous esophageal carcinoma; Synchronous squamous cell tumors; Triple cancer; Triple esophageal carcinoma

Year:  2018        PMID: 29966947      PMCID: PMC6039883          DOI: 10.1016/j.ijscr.2018.05.028

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Reports of multiple synchronous cancers have been increasing due to prolonged lifespan and improvements in diagnostic techniques [1] range from 5% to 20% in the literature [1,2,[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14]]. The most well known is with head and neck and lung similar cancers [1,2,4,11,14,15]. The association between different SCC can be explained from exposure to common carcinogenic agents such as tobacco smoke and alcoholism [[4], [5], [6],11]. Smoking-induced tumor formation through DNA methylation is a common risk factor for patients with multiple primary malignancies, being an example of epigenetic field cancerization induced by exposure to carcinogenic factors [15]. Synchronous multiple cancers in the same organ are well known in colon, stomach and thyroid, but is extremely rare in esophagus. The literature registered only five cases of synchronous and metachronous double SCC of the esophagus [2,4,5,10,12] work has been reported in line with the SCARE criteria.

Case report

A 43-year-old man was referred to our institute with severe progressive dysphagia and epigastric pain for almost one year. Previously he smoked circa 60 cigarettes/day and was alcohol addicted for more than 20 years. Diagnostic evaluation included a complete medical history, physical examination, laboratory blood analyses, and pulmonary and cardiac function tests. All lab exams were normal except for the lower level of the albumin 2.5 mg %. The patient underwent esophagogastroscopy with biopsies, esophagography, chest-abdomen CT with contrast enhancement and bronchoscopy. Tumor stage was determined according to the TNM staging system. Endoscopy and imaging exams revealed three tumors located in upper (20 cm from teeth arcade), middle (29 cm from teeth arcade) and lower (38 cm from teeth arcade) esophagus. The biopsies of the three tumors confirmed the endoscopic impression of squamous cell carcinomas (Fig. 1). The bronchoscopy revealed a hard compression of the right main bronchus due to the middle esophagus tumor invasion. The chest CT demonstrated a three-centimeter-node in the left lung lower lobe suggesting metastasis. A screening to search for other diseases did not show any disorder.
Fig. 1

Photomicrographs of synchronous triple esophageal squamous cell carcinoma (SCC).

A – Invasive SCC associated with chronic inflammatory infiltration. Carcinoma invasion into the upper third of esophageal wall, observe nuclear atypia (arrows). (HE, 100×).

B – Panoramic view of the invasive SCC into the middle thoracic esophagus. The infiltrating tumor into the esophageal corion is indicated by arrows. (HE, 40×).

C – Invasive SCC into the lower third of the esophageal muscle layer. Observe tumor atypical cells inside fibromuscular tissue (arrows). (HE, 100×).

Photomicrographs of synchronous triple esophageal squamous cell carcinoma (SCC). A – Invasive SCC associated with chronic inflammatory infiltration. Carcinoma invasion into the upper third of esophageal wall, observe nuclear atypia (arrows). (HE, 100×). B – Panoramic view of the invasive SCC into the middle thoracic esophagus. The infiltrating tumor into the esophageal corion is indicated by arrows. (HE, 40×). C – Invasive SCC into the lower third of the esophageal muscle layer. Observe tumor atypical cells inside fibromuscular tissue (arrows). (HE, 100×). Esophageal surgical procedure was not considered due to the upper and middle esophageal cancers, which were irresectable, and to the pulmonary metastases. The patient was treated with four cylces of chemoradiotherapy (cisplatin plus fluoropyrimidine) with concurrent 25 cycles radiotherapy. After five months, a gastrostomy was performed due to dysphagia. The patient survived 11 months after the diagnosis and died due to severe progressive undernutrition and bilateral pneumonia. The ethical approval for the publication of this case was exempted by our institution due to the absence of risk to the patient and his family by this article and no research related to this case.

Discussion

Patients with SCC of the esophagus have an increased risk of synchronous cancers, mainly in the aerodigestive tract organs, such as the oral cavity, pharynx, larynx and lung [4,6,8,10,15]. However multiple SCC in the esophagus is a extremely rare event. The literature has shown only five double SCC and none with higher number of tumors [2,4,5,10,12]. This is the first published triple SCC only in the esophagus. Given the well-known harmful effects of smoking and alcohol consuming, including increased risk of cancers such as esophageal, aerodigestive tract and lung cancers, physicians should pay attention to the risk of synchronous SCC in these organs [4,6,8,10]. Recent technical progress in diagnostic methods may affect the clinical features of SCC of esophagus [13]. Endoscopy and PET-CT are the standard modality for SCC of the esophagus diagnosis and staging, demonstrating 100% sensitivity and 89% positive predictive values for endoscopy, and 91% sensitivity and 69% positive predictive values for PET-CT. Conventional CT on its own can miss early malignant lesions due to the mobility of body structures and normal variation [4,13]. In this case with three advanced esophageal cancers, the endoscopy easily diagnosed the three cancers of esophagus and was useful to biopsies of the three tumors. Probably due to the fact all cancers were advanced, the diagnosis and staging these tumors were easily done by the conventional CT without the necessity to perform a PET-CT. For smokers and long-term alcohol consumption, such as the patient of this case, the risk of esophageal SCC is increased. and this tumor should be always considered during the initial medical assessment. Multidisciplinary approach was used for treating this patient [3]. Treatment plans for the three SCC was not optimal due to the unfeasibility of surgical treatment specifically for the upper and middle esophageal carcionomas. The treatment plans for esophagectomy and gastric transposition were altered to non-surgical treatment including definitive chemotherapy radiotherapy and palliative therapy [3]. Under-nutrition was an important negative prognostic factor for this patient.

Conclusion

Physicians should be aware of the co-existence of two or more squamous cells carcinoma of the esophagus during the initial study. In presence of esophageal cancer, propedeutics should be carefully performed in order to verify the occurrence of other synchronous tumors in the esophagus and other organs, mainly head and neck and bronchial regions.

Conflicts of interest

All authors declare NO conflict of interest related to this article.

Funding

All authors declare NO funding sponsored this work and article.

Ethical approval

The ethical approval for the publication of this case was exempted by the Department of Surgery of the School of Medicine of the Federal University of Minas Gerais and by the Santa Casa Hospital of Belo Horizonte due to the absence of risk to the patient and his family by this article and no research related to this case.

Consent

The patient signe the consent form for the publication of this article.

Author contributions

Andy Petroianu is the head of the Surgical Service of Santa Casa Hospital and was responsible for the management of this patient. He wrote the manuscript. Kelly Renata Sabino is Assistant surgeon of the Surgical Service of Santa Casa Hospital and was responsible for the management of this patient. She also wrote the manuscript. Maurício Buzelin Nunes was the Pathologist of this patient. He made the pictures and manuscript.

Registration of research studies

This is not a study, but a case report.

Guarantor

The authors Andy Petroianu, Kelly Renata Sabino and Maurício Buzelin Nunes.

Human rights statement

The authors declare all procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
  14 in total

1.  Metachronous triple cancer: esophageal carcinoma 4 years later the synchronous bilateral bronchogenic carcinoma.

Authors:  Alpay Sarper; Gülay Ozbilim; Abid Demircan
Journal:  Eur J Cardiothorac Surg       Date:  2003-08       Impact factor: 4.191

2.  Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region.

Authors:  Manabu Muto; Mari Takahashi; Atsushi Ohtsu; Satoshi Ebihara; Shigeaki Yoshida; Hiroyasu Esumi
Journal:  Carcinogenesis       Date:  2005-02-17       Impact factor: 4.944

3.  Synchronous triple primary cancers of the pharynx and esophagus.

Authors:  Seita Kataoka; Masami Omae; Yusuke Horiuchi; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Junko Fujisaki; Kazuhiko Yamada; Masahiro Igarashi
Journal:  Clin J Gastroenterol       Date:  2017-03-17

4.  Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome.

Authors:  Shoji Natsugoe; Masataka Matsumoto; Hiroshi Okumura; Sumiya Ishigami; Yoshikazu Uenosono; Tetsuhiro Owaki; Sonshin Takao; Takashi Aikou
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

5.  Synchronous triple cancers at middle and lower esophagus and stomach with different histological features and genetic alterations.

Authors:  Yu-Ting Chang; Chun-I Tsai; Tzeng-Huey Yang; Chia-Wen Shih; Ming-Shiang Wu; Jaw-Town Lin
Journal:  J Gastroenterol Hepatol       Date:  2002-06       Impact factor: 4.029

6.  Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications.

Authors:  R T Poon; S Y Law; K M Chu; F J Branicki; J Wong
Journal:  Ann Thorac Surg       Date:  1998-06       Impact factor: 4.330

7.  A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.

Authors:  J-L Lee; S I Park; S-B Kim; H-Y Jung; G H Lee; J-H Kim; H-Y Song; K-J Cho; W-K Kim; J-S Lee; S-H Kim; Y-I Min
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

8.  The relation between an esophageal cancer and associated cancers in adjacent organs.

Authors:  H Shibuya; T Wakita; T Nakagawa; H Fukuda; M Yasumoto
Journal:  Cancer       Date:  1995-07-01       Impact factor: 6.860

Review 9.  [Two cases of synchronous superficial double cancers in the esophagus and stomach].

Authors:  Koichi Yano; Toshihiro Yamashita; Mariko Chishiki; Toshihiro Osaki; Kenji Sugio; Kosei Yasumoto
Journal:  J UOEH       Date:  2002-06-01

10.  Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.

Authors:  Toshiki Matsubara; Kazuhiko Yamada; Aya Nakagawa
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.